Healthcare provider profile · identity verified

April Y Barr, APRN

Nurse Practitioner · MADISON, IN · NPI 1427503259

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	344	100
Amlodipine Besylate	Amlodipine Besylate	278	75
Omeprazole	Omeprazole	210	71
Losartan Potassium	Losartan Potassium	208	56
Lisinopril	Lisinopril	198	62
Levothyroxine Sodium	Levothyroxine Sodium	188	50
Gabapentin	Gabapentin	184	45
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	177	38
Albuterol Sulfate Hfa	Albuterol Sulfate	165	43
Alprazolam	Alprazolam	130	30
Metformin Hcl	Metformin Hcl	122	35
Alendronate Sodium	Alendronate Sodium	114	35
Furosemide	Furosemide	111	34
Tramadol Hcl	Tramadol Hcl	109	29
Clonazepam	Clonazepam	103	30
Eliquis	Apixaban	97	20
Metoprolol Succinate	Metoprolol Succinate	93	33
Ozempic	Semaglutide	92	20
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	91	28
Potassium Chloride	Potassium Chloride	84	28
Pregabalin	Pregabalin	71	14
Prednisone	Prednisone	66	48
Citalopram Hbr	Citalopram Hydrobromide	64	18
Ondansetron Odt	Ondansetron	64	31
Hydrochlorothiazide	Hydrochlorothiazide	60	20
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	56	13
Trazodone Hcl	Trazodone Hcl	56	16
Metoprolol Tartrate	Metoprolol Tartrate	55	15
Ropinirole Hcl	Ropinirole Hcl	53	15
Sertraline Hcl	Sertraline Hcl	53	17
Duloxetine Hcl	Duloxetine Hcl	51	16
Mounjaro	Tirzepatide	51	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	51	suppressed
Carvedilol	Carvedilol	49	13
Clopidogrel	Clopidogrel Bisulfate	49	15
Escitalopram Oxalate	Escitalopram Oxalate	49	19
Buspirone Hcl	Buspirone Hcl	47	13
Rosuvastatin Calcium	Rosuvastatin Calcium	46	13
Bupropion Xl	Bupropion Hcl	44	12
Simvastatin	Simvastatin	44	12
Zolpidem Tartrate	Zolpidem Tartrate	44	14
Pantoprazole Sodium	Pantoprazole Sodium	43	16
Pravastatin Sodium	Pravastatin Sodium	43	12
Cephalexin	Cephalexin	41	36
Diclofenac Sodium	Diclofenac Sodium	41	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	39	11
Atenolol	Atenolol	38	suppressed
Allopurinol	Allopurinol	37	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	37	suppressed
Celecoxib	Celecoxib	35	suppressed
Hydralazine Hcl	Hydralazine Hcl	35	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	35	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	34	27
Fluticasone Propionate	Fluticasone Propionate	34	13
Spironolactone	Spironolactone	34	11
Sumatriptan Succinate	Sumatriptan Succinate	33	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	32	11
Aripiprazole	Aripiprazole	30	suppressed
Chlorthalidone	Chlorthalidone	30	suppressed
Meloxicam	Meloxicam	30	suppressed
Cefdinir	Cefdinir	29	23
Glipizide Er	Glipizide	29	suppressed
Ibuprofen	Ibuprofen	29	suppressed
Ezetimibe	Ezetimibe	28	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	28	suppressed
Baclofen	Baclofen	27	suppressed
Ondansetron Hcl	Ondansetron Hcl	26	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	25	suppressed
Acyclovir	Acyclovir	24	suppressed
Klor-Con M20	Potassium Chloride	24	13
Montelukast Sodium	Montelukast Sodium	24	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	24	suppressed
Methocarbamol	Methocarbamol	23	suppressed
Propranolol Hcl Er	Propranolol Hcl	23	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	22	suppressed
Meclizine Hcl	Meclizine Hcl	22	suppressed
Famotidine	Famotidine	21	suppressed
Azithromycin	Azithromycin	20	18
Bumetanide	Bumetanide	20	suppressed
Glimepiride	Glimepiride	19	suppressed
Ibandronate Sodium	Ibandronate Sodium	19	suppressed
Prazosin Hcl	Prazosin Hcl	19	suppressed
Ventolin Hfa	Albuterol Sulfate	19	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	18	17
Estradiol	Estradiol	18	suppressed
Lidocaine	Lidocaine	18	suppressed
Naproxen	Naproxen	18	suppressed
Gemfibrozil	Gemfibrozil	17	suppressed
Jardiance	Empagliflozin	17	suppressed
Olanzapine	Olanzapine	17	suppressed
Synthroid	Levothyroxine Sodium	17	suppressed
Glipizide	Glipizide	16	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	16	suppressed
Promethazine Hcl	Promethazine Hcl	16	suppressed
Trulicity	Dulaglutide	16	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	15	suppressed
Lubiprostone	Lubiprostone	15	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	15	suppressed
Warfarin Sodium	Warfarin Sodium	15	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	14	12
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Nurtec Odt	Rimegepant Sulfate	13	suppressed
Spiriva Respimat	Tiotropium Bromide	13	suppressed
Varenicline Tartrate	Varenicline Tartrate	13	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	12	suppressed
Finasteride	Finasteride	12	suppressed
Primidone	Primidone	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Diazepam	Diazepam	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Topiramate	Topiramate	11	suppressed
Valsartan	Valsartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error